1Goh KL. “On-demand”therapy for gastroesophageal reflux disease: Are current proton pump inhibitors good candidates? J Gastroenterol Hepatol, 2006, 21(Suppl 5) :S115-S118.
2Cheung TK, Wong BC. Proton-pump inhibitor failure/resistance: Proposed mechanisms and therapeutic algorithm. J Gastroenterol Hepatol, 2006, 21(Suppl 5):S119-S124.
3Hallerback B, Unge P, Carling L, et al. Omeprazole or raniti-dine in long-term treatment of reflux esophagitis. Gastro-enterology,1994,107:1305-1311.
4Dent J,Yeomans N, Mackinnon M,et al. Omeprazole vs. rani tidine for prevention of relapse in reflux oesophagitis. A controlled double-blind trial of their efficacy and safety. Gut, 1994,35:590-598.
5Ang TL,Fock KM. Nocturnal acid breakthrough:Clinical significance and management. J Gastroenterol Hepatol, 2006,21(Suppl 5): S125-S128.
6Triadafilopoulos G, Dibaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow up of the U.S.open label trail. Gastrointest Endosc, 2002,55:149-156.
7Khajanchee YS, Urbach DR, Butler N, et al. Laparoscopic antireflux surgery in the elderly: surgical outcome and effect on quality of life. Surg Endosc, 2002,16:25-30.
8Leeder PC, Watson DL, Jamieson GG. Laparoscopic fundoplication for patients with symptoms but no objective evidence of gastroesophageal reflux. Dis Esophagus,2002,15:309-314.
9De Vault KR, Castell DO. American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol, 2005,100:190-200.
10Fock KM,Talley N,Hunt R,et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol, 2004, 19:357-367.
